Nucana Biomed Ltd's ticker is and the CUSIP is GB00BYWYV. A total of 1 filers reported holding Nucana Biomed Ltd in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,464,000 | -22.8% | 2,400,000 | 0.0% | 0.09% | -25.8% |
| Q2 2023 | $1,896,000 | -17.7% | 2,400,000 | 0.0% | 0.12% | -15.6% |
| Q1 2023 | $2,304,240 | +45.5% | 2,400,000 | 0.0% | 0.15% | +56.4% |
| Q4 2022 | $1,584,000 | -36.8% | 2,400,000 | 0.0% | 0.09% | -35.6% |
| Q3 2022 | $2,508,000 | +44.1% | 2,400,000 | 0.0% | 0.15% | +0.7% |
| Q2 2022 | $1,740,000 | -27.4% | 2,400,000 | 0.0% | 0.14% | -20.3% |
| Q1 2022 | $2,398,000 | -58.0% | 2,400,000 | 0.0% | 0.18% | -45.5% |
| Q4 2021 | $5,712,000 | -7.8% | 2,400,000 | 0.0% | 0.33% | -9.0% |
| Q3 2021 | $6,192,000 | -6.9% | 2,400,000 | 0.0% | 0.37% | -4.2% |
| Q2 2021 | $6,648,000 | -44.5% | 2,400,000 | 0.0% | 0.38% | -46.8% |
| Q1 2021 | $11,976,000 | -14.4% | 2,400,000 | 0.0% | 0.72% | -44.4% |
| Q1 2020 | $13,992,000 | -4.4% | 2,400,000 | 0.0% | 1.29% | +22.7% |
| Q4 2019 | $14,640,000 | -15.7% | 2,400,000 | 0.0% | 1.06% | -32.8% |
| Q3 2019 | $17,376,000 | -30.3% | 2,400,000 | 0.0% | 1.57% | -31.4% |
| Q2 2019 | $24,912,000 | -38.9% | 2,400,000 | 0.0% | 2.29% | -41.8% |
| Q1 2019 | $40,800,000 | +17.2% | 2,400,000 | 0.0% | 3.93% | -9.3% |
| Q4 2018 | $34,800,000 | -65.1% | 2,400,000 | -40.0% | 4.34% | -51.2% |
| Q3 2018 | $99,680,000 | -34.4% | 4,000,000 | -50.0% | 8.89% | -8.3% |
| Q2 2018 | $152,000,000 | – | 8,000,000 | – | 9.69% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sofinnova Investments, Inc. | 2,400,000 | $1,740,000 | 0.14% |